Corporate DisclosureRENATA
RENATA Corporate Disclosure — 18 December 2024
Announcement summary
- What happened
- RENATA published a corporate disclosure on 18 December 2024. Read the full announcement for details.
- Company
- Renata PLC
- Announcement published
Original announcement
(Continuation news of RENATA): Rolip will now be available in the U.S. market as a bioequivalent and interchangeable formulation to the innovator product. Rolip is available in dosage strengths of 5 mg, 10 mg, 20 mg, and 40 mg tablets. (end)
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
(RENATA-এর ধারাবাহিক সংবাদ): Rolip এখন উদ্ভাবক পণ্যের জৈব সমতুল্য এবং বিনিময়যোগ্য ফর্মুলেশন হিসাবে মার্কিন বাজারে পাওয়া যাবে। Rolip 5 mg, 10 mg, 20 mg, এবং 40 mg ট্যাবলেটের ডোজ শক্তিতে পাওয়া যায়। (শেষ)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 676262c4658c52fc96a21f16
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from RENATA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.